Skip to main content
. 2026 Aug 30;18(9):373. doi: 10.3390/toxins18090373
AOP Adverse Outcome Pathway
CI Confidence interval
CKD Chronic kidney disease
CyanoHAB Cyanobacterial harmful algal bloom
ELISA Enzyme-linked immunosorbent assay
HCC Hepatocellular carcinoma
LC-MS/MS Liquid chromatography-tandem mass spectrometry
MC Microcystin
OATP Organic anion-transporting polypeptide
OR Odds ratio
PECO Population-Exposure-Comparator-Outcome
PP1/PP2A Protein phosphatases 1 and 2A
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
RoB Risk of bias